ISSN: 2165-7386

Journal of Palliative Care & Medicine
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Editorial   
  • J Pallit Care Med 11: 394, Vol 11(2)
  • DOI: 10.4172/2165-7386.1000394

Editor Note on Hematologic Malignancies

Sandra A*
Osmania Medical College, India
*Corresponding Author: Sandra A, Osmania Medical College, India, Email: sandra.a@gmail.com

Received: 02-Feb-2021 / Accepted Date: 12-Feb-2021 / Published Date: 23-Feb-2021 DOI: 10.4172/2165-7386.1000394

Description

Hematologic malignancies are cancers that affect the blood, lymph nodes, and bone marrow. These are heterogeneous group of disease with unique condition or illness. Patients with hematologic malignancies experience high physical and psychological symptoms because of their illness and the treatments that results in adverse effects and toxicity. This classification includes various types of leukemia (acute lymphocytic, chronic lymphocytic, acute myeloid, chronic myeloid, myeloma, and lymphoma). Recently accounted for 9% of newly diagnosed cancers in which lymphomas are more common than leukemia or myeloma. Except lymphoma (may occur during childhood), myeloid cancers increase with advanced age. The palliative cares in patients who are suffering from Hematologic malignancies have shown improved symptom management and quality of life. Treatment involves antitumor antibiotics like Anthracyclines, which is used in variety of hematologic malignancies, these blocks the DNA synthesis and DNA fragmentation by forming a free radical. There will be post-traumatic stress symptoms after the disease has been cured which diminishes their quality of life. However, the new evidence has demonstrated that the acceptability, feasibility and efficacy of palliative care to improve the QOL and care of patients with hematologic malignancies.

Citation: Sandra A (2021) A Note on Hematologic malignancies. J Palliat Care Med 11: 394. DOI: 10.4172/2165-7386.1000394

Copyright: © 2021 Sandra A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Post Your Comment Citation
Share This Article
Recommended Conferences
Article Usage
  • Total views: 1542
  • [From(publication date): 0-2021 - Dec 23, 2024]
  • Breakdown by view type
  • HTML page views: 970
  • PDF downloads: 572
Top